Cargando…

Thrombosis incidence after recombinant active factor VII administration in paediatric cardiac surgery

Detalles Bibliográficos
Autores principales:	Tachi, Keitaro, Takahashi, Shinji, Ishigaki, Maiko, Nakayama, Shin, Yamashita, Soichiro, Hiramatsu, Yuji, Tanaka, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798637/ https://www.ncbi.nlm.nih.gov/pubmed/31649400 http://dx.doi.org/10.4103/ija.IJA_181_19

Ejemplares similares

Use of recombinant activated factor VII after paediatric cardiac surgery
por: Kharkin, A, et al.
Publicado: (2006)

Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery
por: Abdel-Meguid, Mohamed Essam
Publicado: (2013)

Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases
por: Saito, Makoto, et al.
Publicado: (2016)

Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage
por: Heslet, Lars, et al.
Publicado: (2006)

STUDIES IN EXPERIMENTAL EXTRACORPOREAL THROMBOSIS : VII. EXTRACORPOREAL THROMBOSIS IN EXPERIMENTAL OBSTRUCTIVE JAUNDICE AND AFTER THE INTRAVENOUS ADMINISTRATION OF BILE ACIDS.
por: Johnson, Walter R., et al.
Publicado: (1928)

Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing laparoscopic hysterectomy: A case report
por: Dąbrowski, Filip A., et al.
Publicado: (2021)

Paediatric Takayasu’s arteritis complicated by thrombotic occlusion of the distal thoracic aorta
por: Nakata, Tomohiro, et al.
Publicado: (2021)

Occlusion of the pulmonary artery by a primary pulmonary artery sarcoma resulting in cardiac arrest: a case report
por: Tachi, Keitaro, et al.
Publicado: (2019)

Olanzapine attenuates postoperative cognitive dysfunction in adult rats
por: Tachi, Keitaro, et al.
Publicado: (2021)

The Ropivacaine Concentration Required for Ultrasound-Guided Rectus Sheath Block in Pediatric Patients Undergoing Single-Incision Laparoscopic Hernia Repair: A Sequential Allocation Dose-Finding Study
por: Tachi, Keitaro, et al.
Publicado: (2023)

Intrapulmonary administration of recombinant activated factor VII in diffuse alveolar haemorrhage: a report of two case stories
por: Estella, Ángel, et al.
Publicado: (2008)

Perioperative administration of recombinant activated factor VII in a Glanzmannʼs thrombasthenia patient with platelet refractoriness: case report
por: Bisinotto, Flora Margarida Barra, et al.
Publicado: (2021)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013)

Overview of the human pharmacokinetics of recombinant activated factor VII
por: Klitgaard, Thomas, et al.
Publicado: (2008)

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Recombinant activated factor VII in post partum haemorrhage
por: Magon, Navneet, et al.
Publicado: (2013)

The role of recombinant activated factor VII in cardiac surgery
por: Richardson, A, et al.
Publicado: (2009)

Thrombosis in a bleeding disorder: case of thromboembolism in factor VII deficiency
por: Ramdass, Sheryl K., et al.
Publicado: (2017)

Case report: Intraoperative thrombosis cardiac arrest in extended right hepatectomy involving use of local haemostatic agent in intraoperative cell salvage (ICS) and administration of recombinant activated factor VII (rFVIIa)
por: Kyang, Lee S., et al.
Publicado: (2019)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

Recombinant activated factor VII: does it really save lives?
por: Edke, U
Publicado: (2009)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
por: Poon, Man-Chiu
Publicado: (2021)

The Effect of Intravenous Administration of Active Recombinant Factor VII on Postoperative Bleeding in Cardiac Valve Reoperations; A Randomized Clinical Trial
por: Payani, Narges, et al.
Publicado: (2015)

The Institutional Treatment of Consumption: VII. Notes on Administration in a Sanatorium
Publicado: (1916)

Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency
por: Rajpurkar, Madhvi, et al.
Publicado: (2018)

Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation
por: Hollis, Allison L., et al.
Publicado: (2016)

Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
por: Klitgaard, Thomas, et al.
Publicado: (2006)

Recombinant activated factor VII in cardiac surgery – first, do no harm
por: Warren, Oliver J, et al.
Publicado: (2007)

Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma
por: Pusateri, Anthony E, et al.
Publicado: (2005)

Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis
por: Mandal, S. K., et al.
Publicado: (2012)

Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients
por: AlGahtani, Farjah H., et al.
Publicado: (2010)

Safety of activated recombinant factor VII in patients with circulatory assist devices
por: Schneider, AS, et al.
Publicado: (2009)

Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis
por: Bernardi, Francesco, et al.
Publicado: (2021)

Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
por: Aggarwal, Anita, et al.
Publicado: (2004)

Expression of Recombinant Human Coagulation Factor VII by the Lizard Leishmania Expression System
por: Mirzaahmadi, Sina, et al.
Publicado: (2011)

Life-threatening hemorrhage in neonates and children: treatment with activated recombinant factor VII
por: Fischer, D, et al.
Publicado: (2003)

Recombinant human activated factor VII in postpartum hemorrhagic shock: the dark side
por: van Veen, E. J. W., et al.
Publicado: (2007)

Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders
por: Johansson, Pär I, et al.
Publicado: (2010)

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage
por: Schneider, AS, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_harmusuebfd796en9b4rl9oekh